Human immunodeficiency virus-associated dementia: an evolving disease. - Wikidata - awgldk - TriplyDB

Human immunodeficiency virus-associated dementia: an evolving disease.

Human immunodeficiency virus-associated dementia: an evolving disease.

http://www.wikidata.org/entity/Q35112016

about

Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview Paving the path to HIV neurotherapy: Predicting SIV CNS disease HIV Associated Neurocognitive Disorders Neuropathogenesis of HIV-1-associated neurocognitive disorders: a possible involvement of D-serine Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders Transcriptome sequencing of gene expression in the brain of the HIV-1 transgenic rat.Modulation Effect of HIV-1 Viral Proteins and Nicotine on Expression of the Immune-Related Genes in Brain of the HIV-1 Transgenic Rats.Neuropsychological Dysfunction among HIV Infected Drug Abusers The longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning.Acquisition and long-term retention of spatial learning in the human immunodeficiency virus-1 transgenic rat: effects of repeated nicotine treatment.RNA deep sequencing analysis reveals that nicotine restores impaired gene expression by viral proteins in the brains of HIV-1 transgenic rats Pattern of neuropsychological performance among HIV positive patients in Uganda.Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease.PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.Reduced genetic diversity in lymphoid and central nervous system tissues and selection-induced tissue-specific compartmentalization of neuropathogenic SIVsmmFGb during acute infection.Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications.Genetic variation and HIV-associated neurologic disease.Minocycline inhibition of monocyte activation correlates with neuronal protection in SIV neuroAIDS Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia Impact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques.HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya.Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta.Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders.The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders.Circulating proviral HIV DNA and HIV-associated dementia.Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.

P2860

Q26770401-A8938CA9-C24F-4C9E-9A3C-CF31190F3C00 Q26852969-B80F3A55-A801-4B33-944E-04B7A7C1DC92 Q27023968-94F43774-DC0D-4577-A0FC-31C50F9CA306 Q27024914-D5E692BA-7AC3-461F-BFCD-2A78BD07CD32 Q28082139-AF9F322C-96C8-4CA7-A64B-BB886FC5D6B3 Q28488809-E6C47F18-73E0-4E39-9A66-AD0BB7BE6396 Q30276862-A8C76B90-EDE3-4749-8435-F34944EB2C5E Q30389107-B6638B42-9FB0-4A46-AC26-4E65EE04BA7A Q30410418-86BC32B2-D992-444C-BADA-241B124E0832 Q30414070-1C6807DD-A8C3-4DFB-AAE4-CB7F9A658813 Q30418181-4C4B5343-D8AA-4C2E-99C9-87A08ADE2689 Q30445074-16FEA2D7-9824-4C6F-B5F4-0CA7EDA1A32A Q30513406-A6002543-A62D-48CE-BA63-A0651834B69C Q31153188-FCE741BA-5836-4047-B6B5-4C09EB87EA99 Q33311631-DF64BFFF-0FA7-4CB9-A990-DD1408D6358B Q33346244-5781CFDE-4391-4DAF-AE1E-82C70DB8AAFA Q33637117-F366FBFE-3770-4FA0-B5DD-1109E325D38C Q33649838-31F87F85-3DCB-43C0-BC4F-1DB306E4CE33 Q33716348-D19F6883-5772-4519-A792-79176C199123 Q33753132-F729A6F7-7DBD-4184-A45A-D2D161990405 Q33786216-1C201EB6-975B-463A-B0DC-6D5AF1685F64 Q33788874-AA4A27FB-E3F4-4721-83B5-C866DB45D2B7 Q33805298-071E180D-EE43-4D41-AB6C-54BC963BD245 Q33819189-E934F25A-D2E1-4BA5-9EFC-EB8856001111 Q33873798-E2F225E2-4E5F-4B7A-9139-D226033C7287 Q33911855-5D170976-ED2F-41B9-898A-B70989553AE7 Q34033558-3C3E1BA0-703B-4E62-B624-A343659DA84F Q34037622-E850F248-8431-4640-BD69-BE40FBA14D90 Q34091371-9C13FF82-25F8-445E-B090-43DE0D568ED8 Q34193503-2ACD8520-4B15-4638-AFEB-6A4006EC05B7 Q34349192-505DA958-B90F-4B68-AAB5-4538A99254AE Q34406750-E9F56FDD-432B-4882-878B-4341C3EF4211 Q34450960-4FD04834-7776-43D9-AE1E-37B74BF7D3F0 Q34455156-0077D751-5E77-4A1A-B840-1592FBBE53A9 Q34776120-A3825EE3-B63D-49BC-8BFC-9DC41EDCBB1B Q34787585-BAF3B0F5-106A-4416-B5F7-AE40781CB1E2 Q34805533-9F673401-E9C3-4E28-A503-F627AC4A7006 Q34914245-BB44B478-BB98-47C4-A008-67863C1AD887 Q35012478-DC6DD229-5C62-4BF7-ABC7-BF16E55B2F85 Q35023780-AEA59F34-9DD0-4ECD-A689-1E8765BB7186

P2860

Human immunodeficiency virus-associated dementia: an evolving disease.

http://www.wikidata.org/entity/Q35112016

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Human immunodeficiency virus-associated dementia: an evolving disease.

@ast

Human immunodeficiency virus-associated dementia: an evolving disease.

@en

type

label

Human immunodeficiency virus-associated dementia: an evolving disease.

@ast

Human immunodeficiency virus-associated dementia: an evolving disease.

@en

prefLabel

Human immunodeficiency virus-associated dementia: an evolving disease.

@ast

Human immunodeficiency virus-associated dementia: an evolving disease.

@en

P1433

Q35112016-E17FFA8B-C3C9-4966-B8C0-4C4EC5E53932

P1476

Q35112016-05242870-52BA-44ED-8B68-7B1DD1CB570D

P2093

Q35112016-0065CB7A-D2AE-4DAF-B94D-BDB920A8D419

Q35112016-05410767-E1D6-4134-825C-872D69D644E1

Q35112016-3310391B-B251-4083-A433-5B909BCED763

Q35112016-A7ED5592-FDD2-4BC2-B418-D323F44D698B

Q35112016-BA681008-06C8-4AD6-9A0F-666822695C26

Q35112016-EBED8D4B-5078-4611-AC51-064845959E25

P2888

Q35112016-5B7EB604-DD6B-436F-8AE2-2A5EB100F28A

P304

Q35112016-7A2F4065-54C4-487E-91A5-532668025A46

P31

Q35112016-9E186190-E00E-4F5E-A9AA-40600F75469F

P356

Q35112016-4D33A42E-F98A-45A1-A963-035FAD399E38

P433

Q35112016-FC750B35-067A-4B3C-AA02-4416D9027933

P478

Q35112016-D429FE9D-EAD7-4999-A299-C1EB370FA3A0

P50

Q35112016-ACC96E87-8E51-4A20-8A16-E9DF5FFD6E9C

P577

Q35112016-5A5A8BB1-E286-48A5-A42F-8C661D6F7537

P5875

Q35112016-69B3083F-E8B7-4970-A5EC-1A4B29DE2B10

P6179

Q35112016-D27E40E6-7131-48DD-868B-CA186B39B36F

P698

Q35112016-75A8D3D4-683D-4E18-A553-4A042F7837EB

P921

Q35112016-B9BE6A72-EC79-42F6-8A87-5C45E681B88F

P356

13550280390194109

P1433

Journal of NeuroVirology

P1476

Human immunodeficiency virus-associated dementia: an evolving disease.

@en

P2093

Avi Nath

http://www.w3.org/2001/XMLSchema#string

Carlos Pardo

http://www.w3.org/2001/XMLSchema#string

Justin C McArthur

http://www.w3.org/2001/XMLSchema#string

Kathy Conant

http://www.w3.org/2001/XMLSchema#string

Norman Haughey

http://www.w3.org/2001/XMLSchema#string

Suzanne Gartner

http://www.w3.org/2001/XMLSchema#string

P2888

13550280390194109

P304

205-221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13550280390194109

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10793317

http://www.w3.org/2001/XMLSchema#string

P6179

1052280988

http://www.w3.org/2001/XMLSchema#string

P698

12707851

http://www.w3.org/2001/XMLSchema#string

P921